{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:12:16Z","timestamp":1793121136091,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:00:00Z","timestamp":1631318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a small but measurable increased risk of lymphoma in inflammatory bowel disease [IBD], with a suggestion that primary intestinal lymphoma [PIL] in IBD is associated with inflamed tissue and immunosuppressant use, mainly thiopurines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicentre case series was supported by the European Crohn\u2019s and Colitis Organisation [ECCO] and performed as part of the Collaborative Network of Exceptionally Rare case reports [CONFER] project. Clinical data were recorded in a standardized case report form.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen patients with intestinal lymphoma from eight centres were included (12 males, 11 patients with Crohn\u2019s disease [CD], mean age 47.8 [\u00b116.4 SD, range 26\u201376] years at lymphoma diagnosis). Lymphoma type was diffuse large B-cell lymphoma [DLBCL] in eight, Hodgkin\u2019s disease in two, mucosa-associated lymphoid tissue [MALT] lymphoma in three, and single cases of immunoblastic lymphoma and indolent T-cell lymphoma. Lymphoma was located within the IBD-affected area in ten patients. At lymphoma diagnosis, nine patients had a history of azathioprine or anti-tumour necrosis factor [TNF] use. Lymphoma was diagnosed at a mean time of 10.4 [\u00b17.07, 1\u201324] years after IBD diagnosis in 11 patients, prior to IBD in two and concurrently in two. Sustained remission over a median follow-up time of 6.5 [1.5\u201320] years was achieved in ten patients after treatment; five of them had started biological therapy [including anti-TNFs, vedolizumab and ustekinumab] for active CD subsequent to their PIL treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this small case series, two-thirds of patients developed lymphoma in the IBD-affected area, and almost two-thirds had a history of thiopurine or anti-TNF use. Biologics were restarted without recurrence of lymphoma in half of the remitters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab164","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T08:25:30Z","timestamp":1631175930000},"page":"500-505","source":"Crossref","is-referenced-by-count":14,"title":["Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-2390","authenticated-orcid":false,"given":"Frank","family":"Phillips","sequence":"first","affiliation":[{"name":"NIHR Nottingham Digestive Diseases Biomedical Research Centre, Nottingham University Hospitals , Nottingham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-7093","authenticated-orcid":false,"given":"Bram","family":"Verstockt","sequence":"additional","affiliation":[{"name":"University Hospitals Leuven, Gastroenterology and Hepatology , Leuven , Belgium; KU Leuven, Chronic Diseases, Metabolism and Ageing, TARGID-IBD Unit, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3087","authenticated-orcid":false,"given":"Davide Giuseppe","family":"Ribaldone","sequence":"additional","affiliation":[{"name":"University of Turin, Department of Medical Sciences , Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-2515","authenticated-orcid":false,"given":"Ivan","family":"Guerra","sequence":"additional","affiliation":[{"name":"Hospital Universitario de Fuenlabrada and Instituto de Investigaci\u00f3n de La Paz (IdiPaz) , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Teich","sequence":"additional","affiliation":[{"name":"Internistische Gemeinschaftspraxis , Leipzig , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsanos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Ioannina School of Health Sciences , Ioannina , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Filip","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology with IBD Unit of Clinical Hospital 2, University of Rzeszow , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Molnar","sequence":"additional","affiliation":[{"name":"First Department of Medicine, University of Szeged , Szeged , Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karmiris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Venizeleio General Hospital , Heraklion , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ECCO CONFER Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kopylov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ellul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chaparro","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idan","family":"Goren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Gecse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Beaugerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,11]]},"reference":[{"key":"2022062504410559400_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.18.s2.2.x","article-title":"Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease","volume":"18 Suppl 2","author":"Munkholm","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"2022062504410559400_CIT0002","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"2022062504410559400_CIT0003","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/ajg.2011.283","article-title":"Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease","volume":"106","author":"Herrinton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2022062504410559400_CIT0004","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"2022062504410559400_CIT0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"121","author":"Lewis","year":"2001","journal-title":"Gastroenterology"},{"key":"2022062504410559400_CIT0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"2022062504410559400_CIT0007","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.dld.2020.09.011","article-title":"Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study","volume":"53","author":"Ribaldone","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2022062504410559400_CIT0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.1989.tb01585.x","article-title":"Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease","volume":"15","author":"Shepherd","year":"1989","journal-title":"Histopathology"},{"key":"2022062504410559400_CIT0009","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ibd.21516","article-title":"Primary intestinal lymphoma in patients with inflammatory bowel disease: a descriptive series from the prebiologic therapy era","volume":"17","author":"Holubar","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2022062504410559400_CIT0010","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/ibd.22889","article-title":"Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease","volume":"18","author":"Sokol","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2022062504410559400_CIT0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4321\/S1130-01082013000500008","article-title":"Primary intestinal Hodgkin\u2019s lymphoma associated with Crohn\u2019s disease","volume":"105","author":"Salgueiro","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"key":"2022062504410559400_CIT0012","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1445-2197.1997.tb02020.x","article-title":"Primary intestinal Hodgkin\u2019s disease complicating ileal Crohn\u2019s disease","volume":"67","author":"Kelly","year":"1997","journal-title":"Aust N Z J Surg"},{"key":"2022062504410559400_CIT0013","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5694\/j.1326-5377.1978.tb131771.x","article-title":"Hodgkin\u2019s disease as a complication of Crohn\u2019s disease","volume":"2","author":"Hecker","year":"1978","journal-title":"Med J Aust"},{"key":"2022062504410559400_CIT0014","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00004836-200304000-00011","article-title":"Primary intestinal lymphoma complicating Crohn\u2019s disease","volume":"36","author":"Hall","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"2022062504410559400_CIT0015","first-page":"894","article-title":"Primary intestinal lymphoma in Crohn\u2019s disease: minute tumor with a fatal outcome","volume":"87","author":"Perosio","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"2022062504410559400_CIT0016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/gut.33.1.138","article-title":"Rectal lymphoma after colectomy for ulcerative colitis","volume":"33","author":"Teare","year":"1992","journal-title":"Gut"},{"key":"2022062504410559400_CIT0017","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00000478-200001000-00008","article-title":"Epstein-Barr virus-positive primary gastrointestinal Hodgkin\u2019s disease: association with inflammatory bowel disease and immunosuppression","volume":"24","author":"Kumar","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"2022062504410559400_CIT0018","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF02051207","article-title":"Lymphoma of the pouch after ileal pouch-anal anastomosis: report of a case","volume":"40","author":"Nyam","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"2022062504410559400_CIT0019","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.1442","article-title":"Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas","volume":"201","author":"Wong","year":"2003","journal-title":"J Pathol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab164\/40664615\/jjab164.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/3\/500\/44249633\/jjab164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/3\/500\/44249633\/jjab164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:41:21Z","timestamp":1656117681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/16\/3\/500\/6368841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,11]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,11]]},"published-print":{"date-parts":[[2022,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab164","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,9,11]]}}}